Home - Professor Richard Kirk 2023

Professor Richard Kirk

MA FRCP FRCPCH

×

• 

  Transplant
  • Heart Transplant
    • Evaluation
    • Listing Criteria
      • Pediatric
      • Adult
    • Candidate Follow Up
    • Donor Offer
    • Peritransplant Issues
    • Transplant Week 1
    • Transplant Follow Up
    • Rejection
    • Graft Failure
    • Drug Interactions
    • Dallas Transplant Guidelines
  • Lung Transplant
    • Evaluation
    • Listing Criteria
    • Candidate Follow Up
    • Donor Offer
    • Peritransplant Issues
    • Transplant Week 1
    • Transplant FU
    • Rejection
    • Drug Interactions
  • Patient Information
  • Immunology
    • Introduction
    • Background
      • Overview
      • ABO Grouping
      • HLA Structure and Function
      • Cross Matching
      • T cell Biology
      • B cell Biology
      • Plasma Cells and Antibodies
      • Innate Immunity
      • Accommodation_Tolerance
    • Transplant Challenges
      • Immunosuppression
      • Drug Interactions
      • Immunosuppression Adverse Effects
      • ABO Mismatch
      • HLA Mismatch & DSA Management
      • Rejection
    • Conclusion
  • Decision Making
  • Vaccination Schedules - CDC
• 

  Heart Failure
  • Introduction
  • Assessment
  • Investigation
  • Management
    • Acute Care
    • Transition Care
    • Chronic Care
    • Comorbidities
    • Medications
    • ICD Indications
  • Special Conditions
    • Myocarditis
    • Fontan Failure
  • AHA HF Guidelines
    • Introduction
    • Staging and Classification
    • Management for at risk HF
    • HFrEF
    • HRmrEF
    • HFimpEF
    • HFpEf
    • ICD & CRT
• 

  PAH
  • Introduction
  • Definition
  • Diagnostic Algorithm
  • Risk Assessment
  • Treatment
  • Treatment - CHD
  • Medications
• 

  Career
  • Team Building
  • Charity
  • Medical
  • The DOAM Project
  • Publications
  • Presentations
• 

  Search

Go to content

Disclaimer